TVRD
Tvardi Therapeutics·NASDAQ
--
--(--)
--
--(--)
TVRD fundamentals
Tvardi Therapeutics (TVRD) released its earnings on Aug 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -1 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-1
--
Report date
Aug 14, 2025
EPS
Actual | -22.32 | -19.44 | -12.6 | 57.24 | -16.92 | -21.96 | -0.72 | -22.68 | -18.72 | -2.88 | -15.48 | -20.16 | -17.64 | -20.88 | -18.72 | -21.24 | -20.16 | -1.68 | -3.22 | -1 | ||||||||||||
Forecast | -21.69 | -23.9657 | -21.4971 | 13.1143 | -20.64 | -19.74 | -13.9057 | -18.4114 | -19.8514 | -9.4114 | -14.8114 | -12.3429 | -18.4811 | -19.38 | -18.72 | -16.056 | -14.328 | -9.864 | -8.64 | -7.08 | -0.585 | -0.6831 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.90% | +18.88% | +41.39% | +336.47% | +18.02% | -11.25% | +94.82% | -23.18% | +5.70% | +69.40% | -4.51% | -63.33% | +4.55% | -7.74% | 0.00% | -32.29% | -40.70% | 0.00% | 0.00% | +76.27% | -450.43% | -46.39% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.09M | 5.63M | 9.27M | 112.09M | 1.94M | 0 | 20.27M | 821.00K | 4.79M | 23.00M | 10.81M | 3.26M | 6.17M | 6.93M | 4.90M | 3.00M | 2.13M | -- | -- | 0 | 2.57M | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.71M | 5.01M | 4.73M | 5.97M | 3.02M | 2.59M | 15.59M | 1.46M | 2.64M | 21.11M | 8.84M | 14.50M | 4.89M | 6.50M | 9.95M | 9.42M | 1.68M | 1.18M | 2.02M | 1.69M | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +71.98% | +12.36% | +95.96% | +1775.97% | -36.03% | -100.00% | +30.03% | -43.70% | +81.66% | +8.99% | +22.38% | -77.51% | +26.06% | +6.74% | -50.76% | -68.12% | +26.80% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Tvardi Therapeutics's earnings call?What does Tvardi Therapeutics do and what are its main business segments?What is Tvardi Therapeutics's gross profit margin?What is Tvardi Therapeutics's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Tvardi Therapeutics year over year?What were the key takeaways from Tvardi Therapeutics’s earnings call?What factors drove the changes in Tvardi Therapeutics's revenue and profit?What is the market's earnings forecast for Tvardi Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
